At issue in the case is more than abortion rights. It's the entire structure of the FDA's regulatory power to approve drugs and continually evaluate their safety.
At issue is the FDA's regulatory power to approve drugs and continually evaluate their safety — a system that until now has been widely viewed as the gold standard for both safety and innovation
The case could affect not just abortion access but oversight of the drug industry and the authority of federal agencies. The court hears arguments Tuesday.
The plaintiffs in the lawsuit are Missouri, Louisiana and five individuals who were either banned from social media during the pandemic or whose posts, they say, were not prominently featured.
In his State of the Union address Thursday, President Biden highlighted key achievements of his first term and made the case that voters should give him a second. Here are six highlights.
The decision came only weeks after the justices heard oral arguments in the politically sensitive case that put the high court in the middle of the 2024 presidential election.
Abortion proved to be a major issue in the 2022 midterms and again in 2023. This year, the presidential race puts extra attention on the ballot. In Arizona, that means the issue is front and center.
In 2018, the federal government banned bump stocks for that reason, but gun enthusiasts have challenged the regulation in court, contending that only Congress has the power to enact such a ban.
The regulation was enacted at the behest of President Trump after the shooting at a Las Vegas concert killed 60 people and injured 400 — in 11 minutes.
